BC Week In Review | Feb 1, 2017
Clinical News

Cystadrops regulatory update

The European Commission approved an MAA from Recordati for Cystadrops cysteamine to treat corneal cystine crystal deposits in patients ages ≥2 with cystinosis. The eye drop formulation of a cystine-depleting agent has Orphan Drug status...
Items per page:
1 - 1 of 1